BackPsyence Biomedical Overview

Psyence Biomedical Receivables

Latest receivables for PBM: $170K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$174187.00
↑ 39.26% YoYΔ $49107.00 vs prior year quarter

Peer trimmed avg / median

Loading

Psyence Biomedical Receivables History

Loading

Psyence Biomedical vs. peers: Receivables Comparison

Loading

Psyence Biomedical Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Psyence Biomedical (PBM) FAQ

As of the most recent data (September 2025), PBM shows a receivables of $170K. That compares with $130K in the prior-year period — up 39.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PBM's receivables is now $170K (was $130K) — a 39.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Psyence Biomedical is outperforming or lagging.

Tracking PBM's receivables over time shows whether Psyence Biomedical is scaling, shrinking, or reshaping that part of the business. The current reading is $170K That compares with $130K in the prior-year period — up 39.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Psyence Biomedical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $170K) with ownership activity and broader fundamentals.